KRMD Straddle Strategy
KRMD (KORU Medical Systems, Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
KRMD (KORU Medical Systems, Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $176.8M, a beta of 0.42 versus the broader market, a 52-week range of 2.625-6.608, average daily share volume of 154K, a public-listing history dating back to 1994, approximately 80 full-time employees. These structural characteristics shape how KRMD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.42 indicates KRMD has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a straddle on KRMD?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current KRMD snapshot
As of May 15, 2026, spot at $3.92, ATM IV 24.10%, IV rank 0.78%, expected move 6.91%. The straddle on KRMD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on KRMD specifically: KRMD IV at 24.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a KRMD straddle, with a market-implied 1-standard-deviation move of approximately 6.91% (roughly $0.27 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated KRMD expiries trade a higher absolute premium for lower per-day decay. Position sizing on KRMD should anchor to the underlying notional of $3.92 per share and to the trader's directional view on KRMD stock.
KRMD straddle setup
The KRMD straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With KRMD near $3.92, the first option leg uses a $3.92 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed KRMD chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 KRMD shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $3.92 | N/A |
| Buy 1 | Put | $3.92 | N/A |
KRMD straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
KRMD straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on KRMD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on KRMD
Straddles on KRMD are pure-volatility plays that profit from large moves in either direction; traders typically buy KRMD straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
KRMD thesis for this straddle
The market-implied 1-standard-deviation range for KRMD extends from approximately $3.65 on the downside to $4.19 on the upside. A KRMD long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current KRMD IV rank near 0.78% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on KRMD at 24.10%. As a Healthcare name, KRMD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to KRMD-specific events.
KRMD straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. KRMD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move KRMD alongside the broader basket even when KRMD-specific fundamentals are unchanged. Always rebuild the position from current KRMD chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on KRMD?
- A straddle on KRMD is the straddle strategy applied to KRMD (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With KRMD stock trading near $3.92, the strikes shown on this page are snapped to the nearest listed KRMD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are KRMD straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the KRMD straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 24.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a KRMD straddle?
- The breakeven for the KRMD straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current KRMD market-implied 1-standard-deviation expected move is approximately 6.91%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on KRMD?
- Straddles on KRMD are pure-volatility plays that profit from large moves in either direction; traders typically buy KRMD straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current KRMD implied volatility affect this straddle?
- KRMD ATM IV is at 24.10% with IV rank near 0.78%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.